Gevo shares have gained approximately 35 percent year-to-date. The company is focused on developing biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. Gevo reported a net loss of $13.2 million for the fourth quarter of 2012, compared to a net loss of 14.2 million in the year ago quarter.
Going forward ... (see research report)
RESEARCH REPORT ON
You must sign up on the left to download this research report.